RxDoctor Payments Data

Carrie Cole, PA

Physician Assistant · Birmingham, ALNPI 1821369067

Payments from drug & device makers

$2,677in general payments, 2019–2025

Across 142 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$644
  • Lilly USA, LLC$434
  • Abbott$297
  • Bayer$207
  • Exact Sciences$190
  • Pfizer$175
  • plus $728 from 13 others

What the payments were for

  • Food & beverage$2,65699%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,677 in reported general payments places this provider in the 80th percentile of 846 physician assistant providers in Alabama.

See all physician assistant providers in Alabama

Medicare billing

Part B allowed, 2024
$49,856
Medicare patients
220
Services billed
813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$68,459
MounjaroTirzepatide47$56,364
JanuviaSitagliptin Phosphate64$41,284
OzempicSemaglutide32$40,011
JardianceEmpagliflozin41$34,960
TrulicityDulaglutide18$25,585
Tresiba Flextouch U-200Insulin Degludec19$23,067
RybelsusSemaglutide13$22,384
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$13,522
Tresiba Flextouch U-100Insulin Degludec18$10,281
Atorvastatin Calcium214$3,720
Rosuvastatin Calcium102$3,374
Levothyroxine Sodium191$2,687
Levemir FlexpenInsulin Detemir13$2,606
Potassium Chloride94$2,282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$434$81,94965 claims
PfizerEliquis$175$68,45964 claims
Novo NordiskOzempic, Rybelsus$644$62,39545 claims
MerckJanuvia$21$41,28464 claims
Boehringer IngelheimJardiance$22$34,96041 claims
AbbVieSynthroid$45$93913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 846 physician assistant providers in Alabama.

Other physician assistant in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →